Multiple sclerosis (MS) is a chronic inflammatory disease characterized by lymphocyte infiltration and tissue destruction in the central nervous system (CNS). The myelin reactive T cells found in the blood and cerebrospinal fluid of MS patients re in a different state of activation as compared to T cells in normal individuals and thus are thought to be directly involved in the disease pathogenesis. Our long-term goal is to understand the molecular basis for the in vivo activation of autoreactive T cells in MS, providing the basis for rational therapeutic intervention. This project is based on the hypothesis that costimulatory molecules provide the second signal which activates autoreactive T cells which are required to induce autoimmune disease. As we have recently discovered increased expression of B7-1 in acute Ms lesion, the requirement for expression of B7-1 and B7-2 molecules and IL-12 by human glial cells will be examined. In the next aim, the molecular basis for the activated in vivo state of autoreactive T cells in MS patients will be further investigated by comparing myelin antigen-autoreactive peripheral blood T cells in MS patients to controls and determining their capacity to expand in response to antigen presented by CHO cells transfected with MHC class II, DR21, alone or with B7-1 or B7-2 costimulatory molecules and DR2. We will also examine regulatory role of B7-2 expressed on activated T cells, which may be of significance for the disturbed immunoregulation described in MS. Our preliminary data demonstrate that B7-2 expressed on T cells has a lower molecular weight than B7-2 expressed on B cells or CHO cells, and has lost its binding affinity for CD28 but not CTLA4. In our last aim, we will further investigate negative regulatory functions of B7-2 expressed on T cells in a novel CD8 anergy system.
These aims will provide basic information on the role of costimulation and anergy induction in CD4 and CD8 T cells as it may apply to understanding immunoregulation of MS, a human autoimmune disease.
| Sumida, Tomokazu; Lincoln, Matthew R; Ukeje, Chinonso M et al. (2018) Activated ?-catenin in Foxp3+ regulatory T cells links inflammatory environments to autoimmunity. Nat Immunol 19:1391-1402 |
| Meyer Zu Horste, Gerd; Przybylski, Dariusz; Schramm, Markus A et al. (2018) Fas Promotes T Helper 17 Cell Differentiation and Inhibits T Helper 1 Cell Development by Binding and Sequestering Transcription Factor STAT1. Immunity 48:556-569.e7 |
| Chihara, Norio; Madi, Asaf; Kondo, Takaaki et al. (2018) Induction and transcriptional regulation of the co-inhibitory gene module in T cells. Nature 558:454-459 |
| Ordovas-Montanes, Jose; Dwyer, Daniel F; Nyquist, Sarah K et al. (2018) Allergic inflammatory memory in human respiratory epithelial progenitor cells. Nature 560:649-654 |
| Mead, Benjamin E; Ordovas-Montanes, Jose; Braun, Alexandra P et al. (2018) Harnessing single-cell genomics to improve the physiological fidelity of organoid-derived cell types. BMC Biol 16:62 |
| Wu, Chuan; Chen, Zuojia; Xiao, Sheng et al. (2018) SGK1 Governs the Reciprocal Development of Th17 and Regulatory T Cells. Cell Rep 22:653-665 |
| Ponath, Gerald; Lincoln, Matthew R; Levine-Ritterman, Maya et al. (2018) Enhanced astrocyte responses are driven by a genetic risk allele associated with multiple sclerosis. Nat Commun 9:5337 |
| Lucca, Liliana E; Hafler, David A (2017) Resisting fatal attraction: a glioma oncometabolite prevents CD8+ T cell recruitment. J Clin Invest 127:1218-1220 |
| Joller, Nicole; Kuchroo, Vijay K (2017) Tim-3, Lag-3, and TIGIT. Curr Top Microbiol Immunol 410:127-156 |
| Nylander, Alyssa N; Ponath, Gerald D; Axisa, Pierre-Paul et al. (2017) Podoplanin is a negative regulator of Th17 inflammation. JCI Insight 2: |
Showing the most recent 10 out of 205 publications
